My name is Reham Zane. I have a pharmacy doctorate degree and a PhD in pharmacology. I graduated from the University of Houston, Texas.
After that, I pursued a clinical pharmacy degree. I worked in some of the largest hospitals in Texas, Houston, Methodist Hospital. A few years later, I moved to work at Sunrise Hospital and now I’m currently practicing with Kaiser Permanente with LA Kaiser. I am triple board certified.
I currently am board certified in pharmacotherapy, infectious diseases and critical care medicine. Every day I thrive to provide evidence based medicine and the most safest and effective therapies to my patients. Because I care about changing lives and, patients to live better quality of life and live longer, not just live forever, but how they live, the way they live it. And HCODE provides a lot of insights to the patients about how they’re aging and how their organ systems are doing.
And they also provide risk stratifications and next necessary steps that the patients can take to discuss with their physicians and make the necessary plans to prevent disease progression, treat diseases, and make better choices about their lives.
And with me, I find that Genetic LifeSpan, not only it’s a precision wellness company, it also has true clinical validation. And as a healthcare professional who also holds a pharmacology Ph. D, I care about practicing evidence based medicine and I want to do ultimately what’s been studied and scientifically proven to my patients. BGX is, so the way I see it is the future precision medicine.
So healthcare is moving beyond one size fits all medicine. What ultimately I would love to see as a healthcare practitioner is to be able to use patients individual genetic maps to help guide us as clinicians to design therapeutic treatment plans and ultimately do what fits the patients based on their epigenetics, based on their lifestyle, environmental changes that they have, and ultimately make healthcare and medicine more predictive, more preventative, and more precise. I practice a lot in the intensive care unit or critical care medicine, right? Patients ultimately very often come to us when it’s too late.
Sometimes they know about their diseases. Sometimes they find out new information that they never knew from the past. I find that genetic lifespan provides a lot of insights for patients about how they’re doing and all the variables and the, methylation biomarkers, which gives the patient a better control about what changes they can make about their health and life choices. They also provide you with information in a very easily read report, what changes you can make to live longer and ultimately live healthier with the directions that we’re leading to is to utilize how patients’ genes affect the response to medications, correct?
So not everybody absorbs medications the same way they respond to the medications the same way. So we cannot use one size fits all. By using patients’ genetic information, we can actually design so you cannot, for example, treat patients that needs blood thinner with the same blood thinner at the same dose. Patients that have epigenetic like variants or genomic variants, they might respond differently depending on the medications you’re using to treat a specific disease.
So by ultimately tailoring that information and using the right dose, the right treatment ultimately to the patients, you’re making a lot of positive outcomes and you’re affecting patients’ life in the right direction.I’m an academic scientist, involved in academic research all of my career up until the point where I retired and started focusing on biotech industries like Genetic LifeSpan. So, developed a protocol in Canada which was eventually called the Edmonton Protocol to treat patients with type one diabetes. That got me recruited to the University of California Irvine where we focused on stem cell and stem cell technologies to provide insulin producing cells to patients with type one diabetes. So for me Genetic LifeSpan is a novel technology, a comprehensive technology that allows an individual to better understand their health.
It excites me because I think everybody wants to live longer, wants to be healthier, everybody wants to do that, but they really don’t have the tools to do that. So Genetic LifeSpan provides that key component that allows somebody to get the information and then be able to make those changes. And those changes may come about through changes in their diet, changes in exercise, changes in nutritional, but also changes potentially in the future of using some stem cell technologies. We may look in the mirror and see something, but they actually have those hard numbers and to have that information is really critical.
So we can now collect somebody’s blood and bank the immune cells from that. Those cells are the key cells that are going be involved in the future technologies where we take pluripotent stem cells and differentiate them into different cells for different diseases. Diseases include diabetes, Alzheimer’s, Parkinson’s, other neurologicals, autism potentially in the future. So by banking your own immune cells that is your personal bank of your own cells so that when those cells get transplanted there isn’t there isn’t the need to provide immune immunosuppression and immunosuppression is very toxic.
It prevents the body from rejecting but it also inhibits some of these cells from functioning. So my personal testimonial for age code is I took the test and I got my results and I’ve spent time now reviewing my outcomes. My biological age is lower than my actual which is good. So there are some positives but there are also things that were identified that I’ve started to work on.
So opportunities to improve my nutrition, obviously exercise is something that I’ve always had a challenge with. So I’m, you know, more interested in focusing on that so that in three or four months I can go back, redo the test and see what the changes I’ve made, how that’s changed my genetic life span results.
